登录 | 注册    关注公众号  
微信公众号
搜索
 >  Kits>BCMA >EP-127

BCMA [Biotinylated] : APRIL Inhibitor Screening ELISA Kit

For research use only.

IDComponentsSize
EP127-C01High-bind Plate1 plate
EP127-C02Human APRIL 10 μg
EP127-C03Biotinylated Human BCMA10 μg
EP127-C04Anti-BCMA Neutralizing Antibody40 μg
EP127-C05Streptavidin-HRP5 μg
EP127-C06Coating Buffer12 mL
EP127-C0710xWashing Buffer 50 mL
EP127-C08Blocking Buffer50 mL
EP127-C09Substrate Solution12 mL
EP127-C10Stop Solution7 mL

背景(Background)

BCMA (B cell maturation antigen), a member of the tumor necrosis factor receptor family. BCMA is mainly expressed on the surface of advanced B cells, short-lived proliferating plasmablasts and long-lived plasma cells, but not in naive B cells, CD34-positive hematopoietic stem cells and other normal tissue cells. With its specific expression ability, BCMA has become a good diagnostic marker and therapeutic target for multiple myeloma (MM).The main ligands of BCMA are BAFF and APRIL. When BCMA was combined with APRIL, the expression level of immune checkpoint was up-regulated to create an immunosuppressive bone marrow microenvironment. APRIL, as an important ligand of BCMA, is a member of the TNF(Tumor necrosis factor) receptor family (TNFSF-13A), which has 30% sequence homology with BAFF, another ligand of BCMA. But it has a higher affinity to interact with BCMA. It consists of 250 amino acids, of which 28 amino acids encode intracellular regions and 201 amino acids encode type II transmembrane proteins and their extracellular regions. The binding of APRIL to BCMA also induces both classical and non-classical NF-κB pathways, further promoting angiogenesis and metastasis, as well as tumor cell growth and proliferation.

应用说明(Application)

This kit is developed for screening for inhibitors of human BCMA binding to human APRIL.

It is for research use only.

重构方法(Reconstitution)

Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.

存储(Storage)

Unopened kit should be stored at 2°C -8°C upon receiving. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

原理(Assay Principles)

This inhibitor screening Assay kit is designed to facilitate the identification and characterization of new BCMA pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated human BCMA to immobilized human APRIL in a functional ELISA assay, and employs a simple colorimetric ELISA platform. Briefly, we provide you with a human Biotinylated BCMA protein, a human APRIL protein, an anti-BCMA neutralizing antibody (as method verified Std.), and Streptavidin-HRP reagent.

Your experiment will include 4 simple steps:

a) Coat the plate with human APRIL.

b) Add your molecule of interest to the tests.

c) Add human BCMA-Biotin to bind the coated human APRIL.

d) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.

Finally, the ability of your compound to inhibit APRIL: BCMA binding will be determined by comparing OD readings among different experimental groups.

 

典型数据-Typical Data Please refer to DS document for The assay protocol.

BCMA TYPICAL DATA

INHIBITION OF BCMA [BIOTINYLATED]: APRIL BINDING BY ANTI-BCMA NEUTRALIZING ANTIBODY
Serial dilutions of Anti-BCMA Neutralizing antibody (Catalog # EP127-C04) (1:1 serial dilution, from 40 μg/mL to 0.01953125μg/mL) was added into APRIL: Biotinylated BCMA binding reactions. The assay was performed according to the protocol described below. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
BCMA靶点信息
英文全称:B-cell maturation protein
中文全称:B细胞成熟蛋白
种类:Homo sapiens
上市药物数量:6详情
临床药物数量:89详情
最高研发阶段:批准上市
查看更多信息
前沿进展
点击查看详细
相关产品
View All BCMA

消息提示

请输入您的联系方式,再点击提交!

确定